NASDAQ$UFPT

UFP Technologies Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

UFP Technologies reported record Q1 results with increased net sales and income compared to the previous year.

UFP Technologies reported a strong first quarter with a 7.4% organic sales growth in both MedTech and Advanced Components businesses. Operating income and net income increased by 24% and 30%, respectively driven by growth in robotic surgery and infection prevention revenue.

  • Net sales for Q1 2024 were $105.0 million, compared to $97.8 million in Q1 2023.
  • Net income for Q1 2024 was $12.7 million, or $1.64 per diluted share, compared to $9.7 million, or $1.27 per diluted share in Q1 2023.
  • Organic sales growth of 7.4% was achieved in both the MedTech and Advanced Components businesses.
  • Expansion in the Dominican Republic is largely complete, contributing to enhanced gross margins.

Headline financials

Total Revenue

$105M

Previous: $97.8M+7.4%
EPS

$1.64

Previous: $1.57+4.5%
Gross Margin

28.6%

Previous: 29.4%-2.7%
Adjusted SG&A %

12.2%

No prior period
Adjusted EBITDA

$20.7M

No prior period
Capital Expenditures

-$1.73M

Previous: -$2.18M+20.5%
Free Cash Flow

$11M

Previous: $7.56M+45.0%
Net Income

$12.7M

Previous: $9.74M+30.3%
Operating Income

$15.9M

Previous: $12.8M+24.0%
Gross Profit

$30.1M

Previous: $28.7M+4.8%
Cash & Equivalents

$11.4M

Previous: $6.5M+74.9%
Total Assets

$408M

Previous: $391M+4.3%
Stock-Based Comp

$1.51M

Previous: $1.06M+43.3%

Revenue & EPS history

UFP Technologies · Revenue · Quarterly

$105M

Q1 2024+7.4%vs Q1 2023
Beat estimate in 13 of 15 quarters(87%)
ActualEstimate

Revenue by segment

UFP Technologies · $6.8M total across 1 segment · Q3 2023

  • Medical
    $6.8M

Forward guidance

UFP Technologies is optimistic about its future due to continued growth, progress on strategic initiatives, and a strong balance sheet.

Tailwinds

  • Exciting pipeline of active acquisition opportunities, with multiple projects already in the due diligence phase.
  • Continued growth in core business segments.
  • Progress on strategic initiatives.
  • Strong balance sheet with only around $34 million in debt.
  • Mexico operation sales grew 47% over the prior year.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+2.7%

Avg return

Earnings day

+3.1%

Avg return

5 days after

+5.5%

Avg return

30 days after

66%

43 / 65 earnings

Positive

+24.0%

Q1 2024

Best reaction

-11.6%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.2%-1.0%+1.1%
Q4 2025+0.3%-15.1%-21.2%
Q3 2025+12.2%+13.6%+8.6%
Q1 2025+11.2%+19.8%+23.6%
Q4 2024+9.4%-5.5%-15.7%
Q3 2024+23.8%+24.2%+4.5%
Q2 2024+2.8%-5.4%+7.7%
Q1 2024+24.0%+24.5%+26.4%
Q4 2023+10.5%+11.3%+26.2%
Q3 2023-11.6%-8.0%+6.9%
Q2 2023-5.5%-6.3%-9.7%
Q1 2023+5.8%+2.0%+13.9%
Q4 2022+10.8%+2.9%+16.5%
Q3 2022+16.4%+21.5%+31.6%
Q2 2022+11.2%+11.1%+14.1%
Q1 2022+5.9%+3.1%+14.2%
Q4 2021-1.0%-11.1%+1.3%
Q3 2021+4.1%+6.8%+7.6%
Q2 2021+9.6%+12.5%+14.8%
Q1 2021+8.1%+8.8%+15.4%
Q4 2020+1.4%-7.8%-0.7%
Q3 2020+13.2%+18.9%+25.0%
Q2 2020+3.7%+2.5%-6.4%
Q1 2020+1.3%+7.1%+10.0%
Q4 2019+3.0%-4.2%-28.6%
Q3 2019-0.2%+1.3%+7.7%
Q2 2019+2.6%-1.4%-2.2%
Q1 2019+2.8%+3.6%+5.0%
Q4 2018-1.4%-0.2%+8.6%
Q3 2018-0.8%-1.8%+5.1%
Q2 2018+2.7%+10.2%+7.6%
Q1 2018-0.6%-3.2%-6.2%
Q4 2017-3.3%-1.4%+3.7%
Q3 2017-10.1%-11.1%-9.0%
Q2 2017-3.3%-3.8%-8.0%
Q1 2017+1.7%+1.1%+4.9%
Q4 2016+0.4%+1.2%+5.7%
Q3 2016-4.6%-3.5%-4.6%
Q2 2016+3.3%+2.9%+7.5%
Q1 2016+1.3%
Q4 2015+5.6%
Q3 2015-0.6%
Q2 2015+12.7%
Q1 2015-2.7%
Q4 2014-7.5%
Q3 2014+0.9%
Q2 2014-2.1%
Q1 2014-1.2%
Q4 2013+0.1%
Q3 2013-0.9%
Q2 2013+1.4%
Q1 2013-3.4%
Q4 2012-0.6%
Q3 2012-2.5%
Q2 2012+1.3%
Q1 2011+2.5%
Q1 2012+0.6%
Q4 2009-3.0%
Q4 2011-3.0%
Q3 2010+2.6%
Q3 2011+2.6%
Q4 2010+1.3%
Q2 2010+1.3%
Q2 2011+1.3%
Q1 2010+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro